Back to top

UBS Sticks to Their Hold Rating for Qiagen (QGEN)

In a report released today, John Sourbeer from UBS maintained a Hold rating on Qiagen (QGEN – Research Report). The company’s shares closed yesterd...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

QIAGEN N.V. (QGEN)